The Division of Pulmonary and Critical Care Medicine provides expert diagnosis and care of patients with lung diseases, and of critically ill patients in our Intensive Care Unit. Our clinical interests include all areas of lung disease and critical illness, but we have specialized clinical programs in cystic fibrosis, pulmonary hypertension, interstitial lung disease, sleep disordered breathing, acute lung injury, sepsis, alpha-1-antitrypsin deficiency, bronchiectasis, lymphangioleiomyomatosis, hereditary hemorrhagic telangiectasia, tuberculosis, breathing problems resulting from neuromuscular diseases, lung disorders in bone marrow transplant patients, and lung cancer.
In addition to our commitment to outstanding clinical care, we are also proud of our research programs. Areas of active laboratory and/or clinical research include asthma, COPD, cystic fibrosis, surfactant biophysics, nitric oxide physiology in the lungs and upper airway, parasympathetic regulation of the airways, viral infections of the lungs, allergic responses in the airways, tuberculosis immunology and vaccine development, lung carcinogenesis, destructive lung diseases, acute lung injury, sepsis, mechanisms of brain injury after stroke, outcomes in the critically ill, and others. Further information on the research programs can be found on the research portion of this site.
Our educational mission includes teaching on many levels, but specific to our division are our two fellowship programs: one in Pulmonary and Critical Care Medicine and one in Critical Care Medicine. These programs have expanded rapidly over the last several years and provide us with the opportunity to train outstanding clinicians, researchers, and academicians.